Fujian Haixi New Drug Creation Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Fuzhou, Fujian. The company went IPO on 2025-10-20. The Company’s main products include Anbili, Haihuitong, Ruiantuo and Saixifu. The Company’s products are mainly used in digestive system diseases, cardiovascular system diseases, endocrine system diseases, nervous system diseases, inflammatory diseases, oncology, ophthalmology, respiratory diseases and others. The firm mainly operates its businesses in the domestic market.
02637.HK stock price ended at $0 on domingo, after dropping NaN%
On the latest trading day Feb 15, 2026, the stock price of 02637.HK fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for 02637.HK decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.
Señales Técnicas de 02637.HK
Resumen de Señales Técnicas
Señales de compra 0
Señales Neutras 7
Señales de venta 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
02637.HK actualmente presenta 0 señales de compra y 0 señales de venta. La acción ha estado en una tendencia bajista desde --, con un cambio total en el precio de -- durante este período. En general, los indicadores técnicos apuntan a una perspectiva Neutral para el mediano plazo.
Señales alcistas/bajistas para 02637.HK
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para 02637.HK. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.